Westminster, CA – May 17, 2023 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Thursday, May 18, 2023, at 1:30 pm Pacific / 4:30 pm Eastern. The event, which will be open to the public, will be held to review the company’s financial results for the three months ended March 31, 2023, discuss recent milestones, and conduct a question-and-answer session.
To listen to a live broadcast, go
to the site linked below at least 15 minutes prior to the scheduled start time
to register and download any necessary audio/video software.
To participate in the live webcast and teleconference:
|
Webcast Link: |
|
|
Teleconference Domestic: |
888-506-0062 |
|
Teleconference International: Participant Access Code: |
973-528-0011 918886 |
To watch or listen to a replay of the teleconference:
|
Teleconference Replay Expiration: |
Wednesday, May 31, 2023 |
|
Teleconference Replay Domestic: |
877-481-4010 |
|
Teleconference Replay International: |
919-882-2331 |
|
Replay Passcode: |
48436 |
The
webcast replay and accompanying presentation materials will be made available for
90 days on the Investor Relations section of BioLargo’s website at www.biolargo.com/investor-relations.
About
BioLargo, Inc.
BioLargo,
Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering
services solution provider. Our core products address PFAS contamination,
achieve advanced water and wastewater treatment, control odor and VOCs, improve
air quality, enable energy-efficiency and safe on-site energy storage, and
control infections and infectious disease. Our approach is to invent or acquire
novel technologies, develop them into product offerings, and extend their
commercial reach through licensing and channel partnerships to maximize their
impact. See our website at www.BioLargo.com.
Contact
Information
Dennis
P. Calvert
President
and CEO, BioLargo, Inc.
888-400-2863
Safe
Harbor Act
This press
release contains forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These forward-looking statements
include without limitation those about BioLargo’s (the “Company”) expectations
regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans
for future operations. These statements involve risks and uncertainties, and
actual results may differ materially from any future results expressed or
implied by the forward-looking statements. Risks and uncertainties include
without limitation: the effect of the COVID-19 pandemic on the Company’s
business, results of operations, financial condition, and stock price; the
effect of regional economic conditions on the Company’s business, including
effects on purchasing decisions by consumers and businesses; the ability of the
Company to compete in markets that are highly competitive and subject to rapid
technological change; the ability of the Company to manage frequent
introductions and transitions of products and services, including delivering to
the marketplace, and stimulating customer demand for, new products, services,
and technological innovations on a timely basis; the dependency of the Company
on the performance of distributors of the Company’s products. More information
on these risks and other potential factors that could affect the Company’s
business and financial results is included in the Company’s filings with the
SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” sections of the Company’s
most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent
filings. The Company assumes no obligation to update any forward-looking
statements or information, which speak as of their respective dates.
No comments:
Post a Comment